Micro Developing Active

Biogen's acquisition of Apellis Pharmaceuticals

Score
0.5
Velocity
▲ 0.0
Articles
4
Sources
2

Summary

An article belongs to this narrative if it discusses Biogen's acquisition of Apellis Pharmaceuticals or its impact on Biogen's stock.

Related Articles

Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late to Chase APLS Stock?

Yahoo Finance · Apr 02, 2026
Mixed

Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies to portfolio

Yahoo Finance · Apr 02, 2026
Mixed

Sources

Apellis Pharmaceuticals (APLS) Hits 2-Year High on 140% Upside from … Yahoo Finance
Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late … Yahoo Finance
Biogen to acquire Apellis Pharmaceuticals for $5.6B, adding C3 therapies … Yahoo Finance

Timeline

Last Updated Apr 01, 2026